Otezla® (apremilast) is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.
Otezla is a prescription medicine approved for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.
Treat plaque psoriasis differently
Treat psoriatic arthritis differently
*Certain restrictions apply. *Certain restrictions apply; eligibility not based on income.
Otezla® (apremilast) is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.
Otezla is a prescription medicine approved for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.
You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.
Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of having diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.
Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.
Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.
Some medicines may make Otezla less effective, and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.
Side effects of Otezla include diarrhea, nausea, vomiting, upper respiratory tract infection, runny nose, sneezing, or congestion, abdominal pain, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.
Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed. Otezla has not been studied in pregnant women or in women who are breastfeeding.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.
Please click here for Full Prescribing Information.
Just been told you have moderate to severe plaque psoriasis and looking for more information about your condition? Want to connect with others who’ve been there? Whether you need a few ideas about starting the conversation with your dermatologist about treatment or you’re looking for a way to stay on track with Otezla, Otezla SupportPlus™ is here to help. Give us a call at 1-844-4OTEZLA (1-844-468-3952). Our team is available 8 am-8 pm ET, Monday – Friday.
An introduction to Otezla, from diverse viewpoints. A dermatologist, an Otezla patient services professional, and a woman who takes Otezla share their knowledge with us.
ButtonWant to make sure you’re getting the latest on Otezla, including information on savings and tools to help you stay on track and 24/7 access to nurses?
Sign up for Otezla SupportPlusA digital brochure you can take anywhere
is just a click away.
A video that gives you the basic information you need to get started on the right foot with Otezla.
Watch*Certain restrictions apply. *Certain restrictions apply; eligibility not based on income.
Otezla® (apremilast) is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.
Otezla is a prescription medicine approved for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.
You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.
Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of having diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.
Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.
Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.
Some medicines may make Otezla less effective, and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.
Side effects of Otezla include diarrhea, nausea, vomiting, upper respiratory tract infection, runny nose, sneezing, or congestion, abdominal pain, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.
Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed. Otezla has not been studied in pregnant women or in women who are breastfeeding.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.
Please click here for Full Prescribing Information.
You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.
Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of having diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.
The content of the linked site is the sole responsibility of the site provider. Celgene Corporation does not control or endorse this third-party website.
Click "OK" to proceed or "CANCEL" to return to otezla.com.
On November 21, 2019, Amgen acquired the worldwide rights to
Otezla® (apremilast) from Celgene Corporation. Effective November 21, 2019, refer to Amgen's Terms of Use relating to the access of Amgen websites, applications and digital services, and Privacy Statement concerning the collection and use of your personal information. For information collected by Celgene prior to November 21, 2019, refer to Celgene's Terms of Use and Privacy Policy.
On November 21, 2019, Amgen acquired the worldwide rights to
Otezla® (apremilast) from Celgene Corporation. Effective November 21, 2019, refer to Amgen's Terms of Use relating to the access of Amgen websites, applications and digital services, and Privacy Statement concerning the collection and use of your personal information. For information collected by Celgene prior to November 21, 2019, refer to Celgene's Terms of Use and Privacy Policy.